This Thursday, June 30, at 3:00 pm PST. join us for a live discussion with mental and emotional health expert Linda M. Rio, M.A., LMFT. You can find more information on Live Talk, and a link to the studio here. Join us and participate!
Articles of note for people dealing with pituitary disease and related conditions.
Join a drug trial. Find out how. Here’s a partial list of studies.
Brief, insightful commentary from Dr. Lewis Blevins on issues of relevance to pituitary disease.
Just because something is published doesn’t mean it is good
A commentary from Lewis S. Blevins Jr. MD, PWN Co-founder – In my opinion, those of us who “profess” to be
Pituitary World News participates in the World Orphan Drug Congress
From J D Faccinetti - Chairman and cofounder. Join me at the World Orphan Drug Congress USA. July 11 to 13, 2022, in Boston, USA. This is the most comprehensive event dedicated to orphan drugs. I will be moderating and participating in a roundtable to tackle some of the issues related to advocacy and working collaboratively with the industry.
News In Brief
LIVE TALK sessions are now available on Demand. Click here to listen to past shows.
From Recordati Rare Diseases Phase III study confirms the efficacy and safety of ISTURISA®. achieving sustained cortisol control in the majority of patients. Read more
Good news from Amryt Pharma for acromegaly patients in Europe. Read the release from Amryt Pharma on Mycapssa® here.
Corcept Therapeutics announces new communication materials for Phase 3 Trial of Relacolirant in patients with Cushing’s syndrome. Click here to learn more and see if you qualify.
Crinetics Pharmaceuticals moves forward with Paltusotine® phase 3 study. To learn more about the trial and see if you qualify Read more here
Read more about clinical trials from Xeris Pharma, Camurus AB, and Ionis Ph
Content for physicians and healthcare professionals.
The latest from pharmaceutical companies and related organizations
Latest trends and a roundup of health and wellness news
The Podcast
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Decisions made by doctors and their patients can be some of the most complicated, difficult decisions to make. This session focuses on the factors that influence medical decision-making, the impacts those decisions carry, and how the practical clinical aspects of these choices affect our everyday lives.
Semantics, or by definition, the way we relate to different meanings of words or other symbols, are essential. The words we use to communicate and inform are critical. In our session today, we discuss the semantics of pituitary medicine and underline the importance of describing things accurately.
In this podcast, we dive into the world of endocrine nursing with Dr. Chris Yedinak from the Oregon Health and Science University. For the last five years, she has specialized in neuroendocrine testing and pre-and post-operative care of patients with neuroendocrine and pituitary diseases. Nurses play a critical role in the care of patients with pituitary disease and we are delighted to bring you this wonderful conversation.
Apple Podcasts
Spotify
Amazon Music
Google PodcastsMost Popular Articles
Events
The World Orphan Drug Congress, July 10-13, Boston. More details and registration here.
If you missed the recent Acromegaly Community Hybrid Educational Conference May 20-22, 2022 here’s a link to watch some of the presentations
